dosage and administration of monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies

• 收藏
• 分享

专利权人:

INC.;MERRIMACK PHARMACEUTICALS

发明人:

ALEXEY ALEXANDROVICH LUGOVSKOY,BRYAN JOHNSON,JASON BAUM,JIAN TANG,SHARLENE ADAMS

申请号：

BR112014024494

公开号：

BR112014024494A2

申请日:

2013.04.02

申请国别(地区):

BR

年份:

2017

代理人:

摘要：

Summary Dosage and administration of monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies methods are provided for the administration of therapeutic anti-igf-1r and anti-erbb3 antibodies alone or in combination with other therapeutic anti-cancer.resumo dosagem e administração de anticorpos anti-igf-1r e anti-erbb3 monoespecíficos e biespecíficos são providos métodos para a administração de anticorpos anti-igf-1r e anti-erbb3 biespecíficos terapêuticos, sozinhos ou em combinação com outros anti-câncer terapêuticos.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/